Acusphere Inc., of Watertown, Mass., appointed Charles Cox senior vice president, corporate development and marketing.
Adherex Technologies Inc., of Ottawa, Ontario, named Donald Kufe chairman of its scientific and clinical advisory committees.
Aphton Corp., of Miami, appointed David Sachs to its board.
Atrix Laboratories Inc., of Fort Collins, Colo., appointed Lloyd Glenn vice president of marketing and corporate development.
Cepheid Inc., of Sunnyvale, Calif., added Ira Marks as vice president, worldwide sales and marketing.
Corgentech Inc., of South San Francisco, appointed Daniel Gennevois vice president of medical affairs.
Cytogen Corp., of Princeton, N.J., added Christopher Schnittker as vice president and chief financial officer.
De Novo Ventures, of Menlo Park, Calif., added Rajiv Doshi as a principal.
Encysive Pharmaceuticals Inc., of Houston, appointed Terrance Coyne chief medical officer, vice president of clinical development and an officer.
Genentech Inc., of South San Francisco, appointed Marc Tessier-Lavigne senior vice president, research drug discovery, and Richard Scheller executive vice president of research.
Genome BioSciences Inc., of Temecula, Calif., added Gail Martin as a member of its scientific advisory group.
Human Genome Sciences Inc., of Rockville, Md., appointed Perry Karsen senior vice president, business development.
ICN Pharmaceuticals Inc., of Costa Mesa, Calif., appointed Charles Bramlage president, European operations.
Incyte Corp., of Palo Alto, Calif., appointed John Keller executive vice president and chief business officer.